Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

ClinicalTrials.gov ID: NCT03376321

Public ClinicalTrials.gov record NCT03376321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Patients With Influenza A Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the clinical and virologic benefit of pimodivir in combination with Standard-of-Care (SOC) treatment compared to placebo in combination with SOC treatment.

Study identification

NCT ID
NCT03376321
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
334 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
13 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2, 2018
Primary completion
Mar 30, 2020
Completion
Apr 29, 2020
Last update posted
Feb 3, 2025

2018 – 2020

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Nea Baptist Clinic Jonesboro Arkansas 72401
UCSF Fresno Fresno California 93701
Miller Children's at Long Beach Medical Center Long Beach California 90806
Stanford University School of Medicine Stanford California 94306-5640
Destin Pulmonary Critical Care, PLLS. Santa Rosa Beach Florida 32459
Northside Hospital Atlanta Georgia 30342
Augusta University Augusta Georgia 30912
Anne Arundel Medical Center Annapolis Maryland 21401
University Of Maryland Medical Center Baltimore Maryland 21201-1595
Massachusetts General Hospital Boston Massachusetts 02114
Wayne State Univ School of Medicine Detroit Michigan 48201
Henry Ford Hospital Detroit Michigan 48202
Wayne State University Detroit Michigan 97205
Western Michigan University Homer Stryker M.D. School of Medicine Center for Clinical Research Kalamazoo Michigan 49008
William Beaumont Hospital Royal Oak Michigan 48073
William Beaumont Hospital Troy Michigan 48085
Regents of the University of Minnesota Minneapolis Minnesota 55455
Washington University St Louis Missouri 63110
Mercury Street Medical Group, PLLC Butte Montana 59701
Saint Michaels Medical Center Newark New Jersey 07102
Holy Name Medical Center Teaneck New Jersey 07666
Montefiore Medical Center PRIME The Bronx New York 10467
UC Health LLC Cincinnati Ohio 45229
Rhode Island Hospital Providence Rhode Island 02903
Lowcountry Infectious Diseases Charleston South Carolina 29414
University of Texas Southwestern Medical Center Dallas Texas 75390
DM Clinical Research Tomball Texas 77375

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 241 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03376321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03376321 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →